Skip to main content

Table 5 Effect of body fat percentage change on distant metastasis and survival by menopausal status in women with breast cancer

From: Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status

 

Premenopausal (n = 86)

Postmenopausal (n = 45)

B (± SE)

HR (95% CI)

p

B (± SE)

HR (95% CI)

p

Metastasis

 Advanced disease (Stage III)

1.9 (± 0.6)

6.4 (1.83–22.64)

.004

2.5 (± 1.0)

11.7 (1.55–88.07)

.017

 ER positive

1.7 (± 0.9)

5.5 (0.86–35.11)

.071

−0.3 (± 0.9)

0.8 (0.13–4.59)

.781

 PR positive

−1.3 (± 0.8)

0.3 (0.06–1.22)

.088

0.3 (± 0.9)

1.4 (0.21–8.70)

.749

 Age

−0.1 (± 0.1)

0.9 (0.83–0.99)

.029

0.1 (± 0.1)

1.0 (0.90–1.12)

.940

 Regular exercise

−0.4 (± 1.1)

0.7 (0.08–6.00)

.739

0.1 (± 0.7)

1.1 (0.24–4.57)

.945

 Body fat % change

0.1 (± 0.1)

1.1 (0.95–1.21)

.278

0.3 (± 0.1)

1.3 (1.02–1.72)

.035

Death

 Advanced disease (Stage III)

3.2 (± 1.0)

24.7 (3.77–161.63)

.001

4.7 (± 1.9)

106.5 (2.78–4084.85)

.012

 ER positive

2.1 (± 1.3)

8.6 (0.71–103.50)

.091

−0.9 (± 1.3)

0.4 (0.03–4.88)

.476

 PR positive

−2.0 (± 1.1)

0.1 (0.02–1.14)

.067

−0.5 (± 1.4)

0.6 (0.04–10.19)

.749

 Age

−0.1 (± 0.1)

0.9 (0.87–1.11)

.769

0.1 (± 0.1)

1.1 (0.92–1.29)

.298

 Regular exercise

0.3 (± 1.2)

1.3(0.13–13.24)

.815

−1.1 (± 1.1)

0.3(0.04–2.75)

.312

 Body fat % change

0.1 (± 0.1)

1.1(0.95–1.33)

.188

0.4 (± 0.2)

1.5(0.94–2.25)

.091

  1. BMI body mass index, ER estrogen receptor, PR progesterone receptor, CI confidence interval